• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
XUE Lixuan,ZHOU Qianliu,ZHANG Yuanyuan,KOU Junping.Advances of active components of traditional Chinese medicines in the prevention and treatment of sepsis[J].Journal Of Pharmaceutical Research,2019,38(6):311-317,325[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2968times   Download 3379次 QR Code for this article
Scan with your phone!
中药活性成分防治脓毒症的研究进展
薛漓轩1,2,周钱留1,2,张媛媛1,2,寇俊萍1,2
Font:Larger+|Default|Smaller-
(1.中国药科大学中药学院中药药理与中医药系,江苏 南京 211198;2.江苏省中药评价与转换重点实验室,江苏 南京 211198)
摘要:
脓毒症(sepsis)是感染引起宿主反应失调所致的致命性器官功能障碍,其死亡率居高不下,严重威胁人类生命安全,治疗脓毒症的药物研究一直是全球研究的热点。近年来中药有效成分在治疗脓毒症方面取得许多进展,本文拟从抑制脓毒症期间的炎症反应、抑制氧化应激、调节免疫反应、调节细胞死亡、调节内皮屏障功能5个方面对近3年来发表在英文期刊上的中药活性成分防治脓毒症的机制进展予以综述,以期为研发防治脓毒症的新药提供参考依据和线索。
关键词:  中药  活性成分  脓毒症  多器官功能障碍  研究进展
DOI:10.13506/j.cnki.jpr.2019.06.001
基金项目:国家自然科学基金项目(No.81773971)
Advances of active components of traditional Chinese medicines in the prevention and treatment of sepsis
XUE Lixuan1,2,ZHOU Qianliu1,2,ZHANG Yuanyuan1,2,KOU Junping1,2
(1.Department of Pharmacology of Chinese Material Medical, School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing 211198,China;2.Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research,Nanjing 211198,China)
Abstract:
Sepsis is a common critical disease in intensive care unit, also a dysregulated systemic inflammatory and immune response to microbial invasion that produces organ injury. Sepsis has a high mortality rate, which is a serious threat to human life. It’s a hot topic on development of new drug to treat sepsis in global. Many advances of active components from traditional Chinese medicines (TCMs) were reported in the treatment of sepsis in recent years. This article reviews the research progress of TCMs in the prevention and treatment of sepsis reported by foreign journals in the past three years, which includes five aspects such as inhibition of inflammatory reaction, inhibition of oxidative stress, regulation of immune response, regulation of cell death and endothelial barrier function etc, with an attempt to provide the theoretical basis for the development of new drugs for sepsis.
Key words:  Traditional Chinese medicines  Active components  Sepsis  Multiple organ dysfunction  Research progress
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.